NBCC
0
Dr Reddy’s Laboratories: Dr Reddy’s has secured a licensing deal with Ingenus Pharmaceuticals to market Cyclophosphamide injection, used in cancer treatment, ...
Diksha Raj
0
NBCC (India) shares jumped over 4% on Wednesday, May 29, after the company reported strong quarterly results for March 2024. The stock closed at ₹142, up from ...
0
In the world of stocks, the Nifty50 has shown a strong signal with a hammer candlestick pattern on the weekly timeframe. Despite a week of volatility, the ...
Share Price India
0
In a promising development, NBCC (India) Limited's shares made a strong 3 percent gain during early trade on September 22. The state-owned infrastructure ...
